Semaglutide sits alongside Tirzepatide as one of the two highest-demand products in our entire metabolic-disease category, and the fact that it's available in both injectable and oral formulations gives distributors genuine flexibility in matching the product to what a specific market's patients and prescribers are most comfortable with — a distinction that directly affects which formulation a buyer should be ordering.

• Approved indications: Type 2 diabetes mellitus, chronic weight management in adults with obesity or overweight with weight-related conditions
• Mechanism: A GLP-1 receptor agonist that slows gastric emptying, increases insulin secretion in response to food, and reduces appetite through central nervous system pathways
• Formulation distinction: Available as once-weekly subcutaneous injection or once-daily oral tablet — clarifying which format a buyer needs is essential before quoting, since sourcing and pricing differ between the two
• Demand driver: Part of the broader global GLP-1/weight-management surge, alongside Tirzepatide, generating some of the highest enquiry volume across our entire product catalogue

• GI side effects: Nausea, vomiting, and constipation common during dose escalation, generally improving over time as the body adjusts
• Contraindication: Personal or family history of medullary thyroid carcinoma or MEN2 syndrome — a hard contraindication
• Pancreatitis risk: Patients should be counseled on symptoms and advised to seek care for severe abdominal pain
• Gallbladder disease: Increased risk, particularly with rapid weight loss
• Pregnancy: Not recommended

Stock status: Subject to allocation — confirm formulation, quantity, and destination for current availability | Quote turnaround: 24-48 hours given allocation checks

• Logistics: Cold-chain GDP export (2–8°C) for injectable; standard export logistics for oral formulation
• Coverage: Global export markets, with particularly high demand across nearly every region we serve
• Tracking: Full shipment tracking included

What is Semaglutide used for?

Treats type 2 diabetes and supports chronic weight management in adults with obesity or weight-related conditions.

Get Semaglutide price from a GMP-compliant Indian supplier — how?

Send required formulation, strength, quantity, and destination for a verified quote, noting current allocation availability.

Is it available as a tablet or only injection?

Both — Semaglutide is available as a once-weekly injectable pen or a once-daily oral tablet.

Why is availability sometimes limited?

Global demand for GLP-1 drugs currently outpaces manufacturer supply, so allocation-based availability applies industry-wide.

Who supplies Semaglutide from India?

WHO-GMP certified manufacturing partners with full export documentation.